Dr Scot Waterman

News, Articles, Videos and other content about Dr Scot Waterman

Officials Confirm International Drug Summit

As expected the Racing Medication and Testing Consortium board of directors said April 20 it will join the National Thoroughbred Racing Association and American Association of Equine Practitioners in organizing a drug summit.

Sources: Waterman Leaving Post at RMTC

Dr. Scot Waterman, executive director of the Racing Medication and Testing Consortium for almost 10 years, is leaving the post at the end of April, according to multiple industry sources.

Can Public, Fans Understand Drug Testing?

The sensitivity of equine drug testing is a big plus for the racing industry, but it also has created confusion. How are the public and media supposed to understand when some industry participants can't make sense of it?

Drug Testing, Prosecution Focus of Conference

A seminar focused on drug testing and the prosecution of a medication case will be the focus of the Racing Officials Accreditation Programfs second annual Officiating Horse Racing Conference at the University of Arizona Race Track Industry Programfs Symposium on Racing and Gaming.

Changes Ahead for Drug-Testing Protocol

The Racing Medication and Testing Consortium is developing protocol designed to streamline and improve equine drug-testing in the United States. And it is taking a few pages from a 1991 study that didn't gain any traction in the racing industry when it was released.

TOBA Launches Drug Testing Webcast

The Thoroughbred Owners and Breeders Association announced March 26 that it has launched a new webcast entitled "Recent Advances and New Innovations in Equine Drug Testing."

Advances in Equine Drug Testing Revealed

The Thoroughbred Owners and Breeders Association, trainer Michael Matz, and owners Roy and Gretchen Jackson, have invited the public to attend a presentation by Dr. Lawrence R. Soma of the University of Pennsylvania School of Veterinary Medicine's New Bolton Center and Dr. Scot Waterman of the Racing Medication and Testing Consortium.

RMTC Strives for Uniform Drug Testing

RMTC Strives for Uniform Drug Testing

The Racing Medication and Testing Consortium sponsored an equine racing chemist workshop to foster uniformity in drug testing of the androgenic anabolic steroids from April 27-30 at the University of California at Davis.

RMTC Refocusing on Drug Testing, Uniformity

After nearly five years in existence, the Racing Medication and Testing Consortium is refocusing on some of its core goals such as uniform rules, drug research, and standardizing drug-testing procedures in the United States.

Drug Consortium Gets Boost From Hambo Society

  • News

Members of the Hambletonian Society said they've made personal and collective commitments to raise $100,000 for the continued funding of the Racing Medication and Testing Consortium. The decision was made at the July meeting of the society, which has been involved with the RMTC since last year.

Chair of New York Panel Keynote Speaker at Round Table

  • News

J. Patrick Barrett, chairman of the Ad Hoc Committee on the Future of Horse Racing in New York, will discuss the role and work of the committee over the past year when he delivers the keynote address Aug. 20 at The Jockey Club Round Table Conference in Saratoga Springs, N.Y.

Medication Consortium Ramps Up Projects, Fund-Raising Plan

The national Racing Medication and Testing Consortium, which has succeeded in getting most or all of its model rules package for raceday medication and drug testing approved in a majority of jurisdictions, is officially seeking financial commitments from industry stakeholders to support ongoing integrity efforts.

RMTC Addresses Withdrawal Guidelines

The Board of Directors of the Racing Medication and Testing Consortium (RMTC) commissioned Dr. Rick Sams of Ohio State to develop an action plan, timeline, and research priorities to establish guidelines for withdrawal times for therapeutic medications commonly used by racetrack veterinarians.

Drug Consortium Moves on Violations, 'Milkshakes'

The Racing Medication and Testing Consortium has set a deadline for adoption of recommended uniform medication violations and testing protocol for "milkshakes," which are mixtures of bicarbonate of soda and a liquid force-fed to a racehorse before it competes.

Fick Elected Chairman of Medication Consortium

Dan Fick, executive vice president and executive director of The Jockey Club, was elected chairman of the Racing Medication and Testing Consortium at its quarterly meeting Sept. 9. The consortium also approved a per-start fee for horse owners to help fund initiatives.

Drug Consortium Forms Committee to Tackle Security

The Racing Medication and Testing Consortium has approved policy language on race-day use of Salix and non-steroidal anti-inflammatory drugs, as well as environmental contaminants, and also formed a subcommittee to review race-day security practices.

Regulators View Drug Policy; No Race-Day Changes Yet

The Racing Medication and Testing Consortium continued its march toward a national model policy on medication and drug testing Dec. 10 when regulators responded favorably to the proposal. But wholesale changes in race-day medication rules around the country aren't expected to take place any time soon.

Drug Consortium Works on Plan to Fund Initiatives

With a goal to raise $2 million to $3 million a year to support its initiatives, the Racing Medication and Testing Consortium is looking at a mechanism that would raise money from horsemen and racetracks based on the top four finishers in each race.

Panelists: Medication Not Sole Reason for Fewer Starts

Participants in a July 10 medication workshop reached the consensus that "over-medication" may contribute to fewer starts by racehorses, but other factors -- racetrack surfaces, an emphasis on speed, too much pressure on 2-year-olds, and a thirst for quick profit -- probably are just as responsible.

Stakes Grades to be Tied to Drug-Testing Plan

The American Graded Stakes Committee will begin implementing a drug-testing plan for horses participating in its designated races beginning at Keeneland and Belmont Park this fall. It expects to have the testing protocol fully in place by the end of 2004.

Drug Consortium Elects Officers; Progress on Policy

The Racing Medication and Testing Consortium has elected officers, chosen an executive director, and put the finishing touches on few sections of its proposed model policy for medication and drug testing. Breeders' Cup president D.G. Van Clief Jr. was elected chairman.

Medication Consortium Incorporates, Broadens Scope

The Racehorse Medication and Testing Consortium formed earlier this year has incorporated as a charitable organization and issued its goals and objectives, one of which has been broadened to include the auction and training aspects of the Thoroughbred business.

Equine Genomics, Ownership Among Topics for the 50th Round Table

Issues surrounding ownership, medication, equine genomics and the globalization of racing will be spotlighted when The Jockey Club's 50th annual Round Table Conference on Matters Pertaining to Racing convenes at the Sheraton Hotel and Conference Center in Saratoga Springs, N.Y., on Aug. 18.

Super Tests: Calls for Therapeutics Not Unexpected

In the second round of "super tests" performed under the guidance of the National Thoroughbred Racing Association Racing Integrity and Drug Testing Task Force, there were no new positives for Class 1, 2, and 3 medications, according to a final report recently released. There were, however, 454 confirmations for therapeutic drugs.

Therapeutic Medications in Spotlight Once Again

As the National Thoroughbred Racing Association Racing Integrity and Drug Testing Task Force prepared to release the results of round two of its super-testing program, the University of Florida appropriately kicked off its first Equine Medical Symposium March 14 with discussion on some therapeutic medications.

Gallagher Leaves NTRA for NYRA Position

  • News

Jim Gallagher, executive director of the National Thoroughbred Racing Association Racing Integrity and Drug Testing Task Force, will leave the organization March 28 to take the position of vice president of pari-mutuel operations for the New York Racing Association.

'Super-Test' Results, Round Two, Due in January

The second round of "super-test" results from the National Thoroughbred Racing Association Racing Integrity and Drug Testing Task Force should be released early in January, said Jim Gallagher, executive director of the task force.

Task Force to Reach Out to Other Breeds

The National Thoroughbred Racing Association's Racing Integrity and Drug Testing Task Force will attempt to break down barriers that separate breeds in an attempt to shore up drug-testing procedures in horse racing.

Therapeutic Medications Next on 'Super-Test' List

Therapeutic medications will be the focus of the next round of "Super-Testing," the results of which should be available the first week of December during the University of Arizona Symposium on Racing. More than 500 blind samples remain to be tested for Class 4 medications.

Most Popular Stories